EUVIMEDEUVIMED entdecken
Kohortenstudie

Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort Study

Maria Elena Cabrera iD, Monica Civallero iD, Yana Stepanishyna iD, Lea Derio, Tetiana Skrypets iD, Vivianne Lois, Valeska Vega, Susana Calderon, Hernán Rojas, Alvaro Pizarro, M Gabriela Mendoza iD, Monica Romero und 7 weitere

JCO Global Oncology · 2025

DOI: 10.1200/go-24-00344 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift JCO Global Oncology, 2025. Verfasst von Maria Elena Cabrera und 18 weiteren Autor:innen. Beteiligte Einrichtung: Hospital del Salvador, Universidad de Chile, Santiago de Chile, Chile. Hauptthemen laut MEDLINE: Hodgkin Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Hodgkin lymphoma (HL) is classified as the first malignancy to be cured by a combination of chemotherapy and radiotherapy. However, the life expectancy of HL survivors is hampered by the occurrence of late adverse events, including second malignant neoplasms (SMNs) and cardiovascular diseases (CVDs). PATIENTS AND METHODS We investigated the causes of death in a cohort of 1,435 patients over age 15 years treated at 18 different public cancer centers in Chile. RESULTS After a median follow-up of 19 years (0-37), the 5-year overall survival improved from 64% in the cohort 1985-1994 to 81% in the cohort 2009-2014 ( P < .001). HL was the main cause of death in the first 10 years after treatment, whereas SMN and CVD risk peaked 10-15 years and remained raised for 30 years or longer. Cumulative incidence of deaths (CIDs) due to SMNs resulted significantly higher in patients treated with cyclophosphamide, vincristine, procarbazine, prednisone (MOPP)/MOPP-like regimens over doxorubicin, bleomycin, vinblastine, dacarbazine. CIDs due to CVDs increased from 0.4 to 4.1 at 5 and 20 years, respectively. CONCLUSION HL survivors continue to have a reduced life expectancy due to an increased risk of dying of SMNs and/or CVDs, although it was lower among patients treated in the most recent calendar period studied (2002-2014).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseHumansChileMaleFemaleAdultMiddle AgedAdolescentCohort StudiesYoung AdultCause of DeathAgedAntineoplastic Combined Chemotherapy ProtocolsNeoplasms, Second PrimaryDoxorubicin

Substanzen

Doxorubicin

Autor:innen und Institutionen

  • Hospital del Salvador, Universidad de Chile, Santiago de Chile, Chile.
  • CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy.
  • Hematology Department, Jules Bordet Institute, Brussels, Belgium.
  • Oncology Nurse, Public Health Magister, Universidad de Chile, Universidad Mayor, Santiago de Chile, Chile.
  • Hematology Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.
  • Hospital Barros Luco Trudeaux, Santiago, Chile.

ORCID-Profile: Maria Elena Cabrera, Monica Civallero, Yana Stepanishyna, Tetiana Skrypets, M Gabriela Mendoza, Christine Rojas, Luana Conte, Massimo Federico

Zitieren

APA

Cabrera, M. E., Civallero, M., Stepanishyna, Y., Derio, L., Skrypets, T., Lois, V., Vega, V., Calderon, S., Rojas, H., Pizarro, A., Mendoza, M. G., Romero, M., Rojas, C., Oliva, J., Intriago, M., Rojas, B., Conte, L., Marcheselli, L., & Federico, M. (2025). Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort Study. JCO Global Oncology. https://doi.org/10.1200/go-24-00344

Vancouver

Cabrera ME, Civallero M, Stepanishyna Y, Derio L, Skrypets T, Lois V, et al. Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort Study. JCO Global Oncology. 2025. doi:10.1200/go-24-00344

BibTeX
@article{Cabrera2025,
  author = {Cabrera, Maria Elena and Civallero, Monica and Stepanishyna, Yana and Derio, Lea and Skrypets, Tetiana and Lois, Vivianne and Vega, Valeska and Calderon, Susana and Rojas, Hernán and Pizarro, Alvaro and Mendoza, M Gabriela and Romero, Monica and Rojas, Christine and Oliva, Jacqueline and Intriago, Marvila and Rojas, Bernardita and Conte, Luana and Marcheselli, Luigi and Federico, Massimo},
  title = {Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort Study},
  journal = {JCO Global Oncology},
  year = {2025},
  doi = {10.1200/go-24-00344}
}
Kostenlos starten →